Clinical Study for Early Application of Ivabradine on Acute Anterior Myocardial Infarction Patients After PCI With Early Heart Failure to Observe Cardiac Function and Prognosis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032731

Enrollment

Unknown

Registered

2020-05-08

Start date

2020-05-18

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

experimental group:Routine treatment plus ivabradine

control group:Routine treatment

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as acute anterior myocardial infarction who received emergency PCI; 2. ECG showed sinus rhythm, and ventricular rate >= 75 times / min; 3. Patients aged 18-85 years.

Exclusion criteria

Exclusion criteria: 1. With history of asthma; 2. With history of bradyarrhythmia; 3. Systolic pressure <= 90mmHg; 4. PCI 6h later, vasoactive drugs were still used due to shock.

Design outcomes

Primary

Measure	Time frame
Left ventricular end diastolic volume;	—

Secondary

Measure	Time frame
Left ventricular end systolic volume;Left ventricular end diastolic diameter;Left ventricular end systolic diameter;Left ventricular ejection fraction;Brain natriuretic factor;troponin;myoglobin;creatine kinase isoenzyme;heart rate;blood pressure;Canadian angina score;Major adverse cardiac events;	—

Countries

China

Contacts

Public ContactJunqing Gao

Central Hospital of Shanghai Putuo District

kevingjq@sina.com+86 13816985971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026